Thursday, 24 September 2026European Markets
ExploreSearch
ViaNews EU
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 21, 2026

Radiation Dose Management Market Set for Strategic Growth, New Report Offers Critical Insights and Competitive Advantage | Astute Analytica

View original at finance.yahoo.com
Radiation Dose Management Market Set for Strategic Growth, New Report Offers Critical Insights and Competitive Advantage | Astute Analytica AstuteAnalytica India Pvt…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Software platforms have helped reduce protocol deviation errors by as much as 52%

    80% confidence

  • United States and Germany together account for 45% of all AI-related patents in radiation dose management

    80% confidence

  • CT and MRI scans have increased by an average of 12% annually since 2020

    80% confidence

  • Hospitals dominate the radiation dose management market, capturing approximately 50% of the share

    80% confidence

  • 78% of U.S. hospitals had deployed AI-powered dose management systems such as Bayer's Radimetrics and GE HealthCare's DoseWatch by 2024, reflecting a 25% increase in adoption since 2022

    80% confidence

  • The global radiation dose management market was valued at US$ 764.2 million in 2024 and is projected to hit the market valuation of US$ 2,301.3 million by 2033 at a CAGR of 13.03% during the forecast period 2025–2033

    80% confidence

  • 68% of U.S. hospitals operate two or more CT scanners

    80% confidence

  • The software segment holds a commanding 70% share of the radiation dose management market

    80% confidence

  • 78% of U.S. hospitals have adopted AI-enabled dose monitoring software in response to the Joint Commission's 2024 imaging safety standards

    80% confidence

  • Medic Vision's FDA-cleared AI platform reduces fluoroscopy time during cardiac procedures by up to 30%

    80% confidence

  • 92% of hospitals accredited by the Joint Commission utilize automated dose tracking systems to adhere to the 2024 update of TJC Standard PC.01.03.01

    80% confidence

  • By 2024, approximately 65% of U.S. hospitals had deployed advanced dose management solutions like Bayer's Radimetrics or GE HealthCare's DoseWatch

    80% confidence

  • Cardiac CT scans used for coronary artery screenings in Europe have surged by 25% between 2022 and 2024

    80% confidence

  • United States accounts for approximately 75% of North America's radiation dose management market activity

    80% confidence

  • Only 53% of outpatient centers have adopted automated dose tracking technologies

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI Agents Go Mainstream, But Trustworthy Data Access Lags Adoption
A wave of enterprise AI agent activity — fresh funding (Latitude's $35M Series A), a run of CB Insights CEO interviews spotlighting fintech- and healthcare-focused agent startups (Covecta, Penguin AI, Maisa AI), and major platform partnerships (Microsoft-Mistral, Manulife-Microsoft AI governance, Siemens-NVIDIA agentic EDA, Box's agent security controls) — signals agentic AI moving from pilot to production across financial and enterprise workflows. Yet Google Cloud's own research shows adoption is outrunning data readiness (companies average AI access to only 45% of their data, with 'data laggards' capped near 30%), while insider selling at incumbent C3.ai hints at mixed investor conviction even as the broader ecosystem accelerates.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,983
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,983 facts checked against source5,305 source documents archived
Query this data → isubstrate.com
Radiation Dose Management Market Set for Strategic Growth, New Report Offers Critical Insights and Competitive Advantage | Astute Analytica — Source | Via News | ViaNews EU